Keyword: Elanco

Lilly picks up BI’s pet vaccines for $885M

Eli Lilly rocketed into the No. 3 spot among the world’s top animal health companies when it picked up Novartis Animal Health for $5.4 billion last year--and now it’s set to strengthen its position even more. The company’s Elanco division will acquire Boehringer Ingelheim’s dog and cat vaccines, along with a manufacturing and R&D site in Fort Dodge, Iowa, for $885 million.

Lilly’s Elanco vows to be ‘a lot bigger’ in aquaculture

Eli Lilly has been doubling down on its efforts to invent new animal vaccines, but until now it has been mostly focused on cattle and swine products. Now the company's animal health unit, Elanco, is looking to expand into a rapidly growing corner of food production where it has had virtually no presence: aquaculture.